ACell, Inc. Announces New Distribution Agreement with Applied Tissue Technologies LLC
February 21, 2018 at 12:15 pm
Share
ACell, Inc. announced a new distribution agreement with Applied Tissue Technologies LLC. ACell will be the exclusive US distributor of ATT's Xpansion micro-autografting kit, which offers a novel approach to split-thickness skin grafting procedures used to manage complex wounds. Autologous split-thickness skin grafts are the standard of care for achieving wound closure in many clinical settings. However, the procedure still has challenges, including poor skin quality, infections, scarring, and poor cosmetic outcomes. In addition, the need to harvest skin from the patient can lead to additional donor site complications. The Xpansion micro-autografting kit facilitates durable closure of complex wounds while maximizing the ratio of donor skin to wound bed area – minimizing the size of painful donor sites. In addition, the kit can be used with only local anesthetic, providing physicians with the option to perform procedures outside of the operating room.
ACell Inc is a United States-based company that provides wound management solutions. The Company offers a range of products, including Cytal Burn Matrix, which is a medical device used for the management of second degree burns; Cytal Wound Matrix, which is are used for acute wounds and chronic wounds; Gentrix Surgical Matrix, which is used in a range of surgical procedures, including various types of hernia repair, and MicroMatrix, which is used for acute wounds and chronic wounds. The Company uses MatriStem UBM (Urinary Bladder Matrix) technology for the manufacturing of Gentrix, Cytal, and MicroMatrix product lines.